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Background:  
Monitoring the influenza antiviral susceptibility 
had become an important issue in the recent 
years. The influenza A viruses are naturally 
susceptible to Neuraminidase inhibitors (NAI) and 
M2 inhibitors (adamantanes). The increased 
resistance to oseltamivir and adamantanes (since 
2006), the availability and clinical use of influenza 
antivirals enhanced the need for a close 
monitoring for loss of susceptibility. Since 2009, at 
Portuguese National Influenza Centre, was 
developed in the scope of the National Influenza 
Surveillance Programme a systematic monitoring 
of antiviral susceptibility (oseltamivir, zanamivir 
and adamantine). 
This study shows the results of antiviral 
susceptibility to NAI and M2 inhibitors for 
influenza A viruses characterized between 2009 
and 2013. 
Material and Methods:   
The phenotypic method, fluorescence NA 
inhibition assay, considered the “gold standard”, 
to determine the susceptibility to oseltamivir and 
zanamivir, measuring the concentration of the 
antiviral to inhibit 50% of NA activity (IC50) was 
performed during the study period for 119 
influenza A viruses:  26 and 60 A(H1)pdm09 from 
2009/10 and 2012/13 season, respectively, and 
33 A(H3) viruses from 2011/12, plus 2 A(H3) from 
the last season were also analysed. Genotypic 
screening methods were performed for the most 
common NAI inhibition-reducing substitution, 
H275Y in A(H1)pdm09 viruses (n= 340). Matrix 
gene sequencing, for adamantanes susceptibility 
surveillance, and neuraminidase gene 
sequencing were performed for 64 and 119 
strains, respectively. 
Results:  
In the study period all A(H1)pdm09 and A(H3) 
viruses, carried the S31N substitution in the M2 
protein, which confers resistance to the 
adamantanes to 100% of the isolates.  
For A(H1)pdm09 viruses, the oseltamivir IC50 
values (Figure 1) ranged from 0.45 to 2.82 
(2009/2010) and from 0.15 to 2.27 (2012/2013). 
 The resistance to oseltamivir was identified in 3 
A(H1)pdm09 viruses that carried the H275Y 
substitution (Table I). One case in 2009/2010 
(pandemic season) from an 8 years old child 
(phenotypically showed a IC50 of 502.48nM, a 
value 700-fold higher when comparing to the 
susceptible viruses. Two other cases of 
resistance were detected in 2010/2011 (Table I) 
but they were not submitted to phenotypical 
assays. Both the 8 year old child from 2009/2010 
and the 26 year old (pregnant) woman with a fatal 
outcome from 2010/2011 season were patients 
with chronic diseases. The second case from 
2010/2011 is a community-acquired resistance 
detected in a ILI-case. 
The A(H1)pdm09 IC50 values for zanamivir 
(Figure 2) ranged from 0.32 to 3.88 (2009/2010) 
and from 0.29 to 3.44 (2012/2013). The 
oseltamivir and zanamivir median IC50 values for 
A(H1)pdm09 viruses were stable between 2009 
and 2013 (Table II).  
None of the A(H1)pdm09 isolates presented the 
other substitutions associated with reduced 
susceptibility to NAI (D119N, I223R, N295S). 
Conclusions:  
Influenza A viruses isolated in Portugal since 2009 are resistant to adamantanes, which are no longer 
indicated for influenza A treatment.  Otherwise, the resistance to oseltamivir was only observed in a 
reduced number of strains and all the viruses show susceptibility to zanamivir. The use of conventional 
sequence analysis and genotypic screening methods for monitoring the molecular markers of antiviral 
resistance in influenza A virus provides a valuable tool for an early detection of antiviral resistant strains. 
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Table II – Number of viruses analysed and oseltamivir and zanamivir IC50 baseline levels for influenza A in 3 flu seasons 
(2009/2010, 2011/2012 and 2012/2013). 
Figure 2 –  Zanamivir IC50 values for influenza A(H1)pdm09 
in 2009/2010 and 2012/2013 flu seasons . 
Figure 3 –  Oseltamivir IC50 values for influenza A(H3) in 
2011/2012 and 2012/2013 flu seasons. 
Figure 4 –  Zanamivir IC50 values for influenza A(H3) in 
2011/2012 and 2012/2013 flu seasons. 
The A(H3) viruses analysed in 2011/2012 season showed IC50 values for oseltamivir (Figure 3) that 
ranged from 0.19 to 0.90 and for zanamivir from 0.39 to 1.48 (Figure 4). The median IC50 values for 
oseltamivir and zanamivir were 0.41±1.55 and 0.59±1.21 respectively (Table 1). In the last season 
2012/2013 only two A(H3) isolates were analysed and the IC50 values were in the same range of the 
2011/2012 A(H3) viruses. Since 2009 all the A(H3) viruses are susceptible to oseltamivir and zanamivir. 
None of the A(H3) viruses presented the amino acid substitutions known to reduce susceptibility to NAI 
(E119V/I, R229K, N294S and H274Y). 
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Table I – Oseltamivir resistant influenza A(H1)pdm09 virus and  epidemiological and laboratory data from cases detected in 
2009/201 and 2010/2011 seasons. 
Figure 1 –  Oseltamivir IC50 values for influenza A(H1)pdm09 
in 2009/2010 and 2012/2013 flu seasons . 
NA- non available; UNK- unknown 
NA- non available 
A(H1)pdm09 
A(H3) 
Oseltamivir Zanamivir
2009/2010 A/Lisboa/171/2009 A(H1)pdm09 Phenotypic (MUNANA) 502,48 2,31 275Y 8 M chronic disease
VIR1204918 A(H1)pdm09 Genotypic (PCR H275Y) NA NA 275Y 26 F chronic disease
EVA216 A(H1)pdm09 Genotypic (PCR H275Y) NA NA 275Y 61 F UNK
NA 
H275Y 
mutation
Age Sex
Underlying 
Conditions
2010/2011
IC50
MethodVirus
Isolate or 
sample name
Season
n Oseltamivir Zanamivir n Oseltamivir Zanamivir n Oseltamivir Zanamivir
A(H1)pdm09 26 0,70±1,58 0,53±1,40 0 NA NA 60 0,87±2,08 0,80±1,56
A(H3) 0 NA NA 33 0,41±1,55 0,59±1,21 2 0,42±1,44 0,76±1,24
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*  In 2012/2013 season only 2 virus A(H3) were tested. Were considered the minor and major outlier threshold of the previous season for analysis.  
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